In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
about
In vitro bactericidal and bacteriolytic activity of ceragenin CSA-13 against planktonic cultures and biofilms of Streptococcus pneumoniae and other pathogenic streptococci.Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins.Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis.Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
P2860
In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vitro activities of the nov ...... from cystic fibrosis patients.
@en
In vitro activities of the nov ...... from cystic fibrosis patients.
@nl
type
label
In vitro activities of the nov ...... from cystic fibrosis patients.
@en
In vitro activities of the nov ...... from cystic fibrosis patients.
@nl
prefLabel
In vitro activities of the nov ...... from cystic fibrosis patients.
@en
In vitro activities of the nov ...... from cystic fibrosis patients.
@nl
P2093
P2860
P356
P1433
P1476
In vitro activities of the nov ...... from cystic fibrosis patients.
@en
P2093
Ayse Alev Gerceker
Cagla Bozkurt-Guzel
Paul B Savage
P2860
P304
P356
10.1159/000335588
P577
2011-01-01T00:00:00Z